Its NBT equipment is FDA cleared for the treatment of major depressive disorder in the US and CE approved in Europe for depression and chronic neuropathic pain.. Additionally, Nexstim markets NBS equipment for preoperative mapping of the cerebral cortex and brain speech regions.. Founded in 2000, Nexstim is committed to improving patients' quality of life by providing personalized and effective therapies and diagnostics for unmet clinical needs.